We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
- Authors
Benator, Debra; Bhattacharya, Mondira; Bozeman, Lorna; Burman, William; Cantazaro, Antonino; Chaisson, Richard; Gordin, Fred; Horsburgh, C Robert; Horton, James; Khan, Awal; Lahart, Christopher; Metchock, Beverly; Pachucki, Constance; Stanton, Llewellyn; Vernon, Andrew; Villarino, M Elsa; Wang, Yong Chen; Weiner, Marc; Weis, Stephen; Tuberculosis Trials Consortium
- Abstract
Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. We aimed to compare rifapentine and isoniazid once a week with rifampicin and isoniazid twice a week.
- Publication
Lancet (London, England), 2002, Vol 360, Issue 9332, p528
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(02)09742-8